Ho | Nanodiamonds | E-Book | www.sack.de
E-Book

E-Book, Englisch, 286 Seiten

Ho Nanodiamonds

Applications in Biology and Nanoscale Medicine
1. Auflage 2009
ISBN: 978-1-4419-0531-4
Verlag: Springer-Verlag
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

Applications in Biology and Nanoscale Medicine

E-Book, Englisch, 286 Seiten

ISBN: 978-1-4419-0531-4
Verlag: Springer-Verlag
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)



Nanodiamonds: Applications in Biology and Nanoscale Medicine highlights the translation of nanodiamonds toward clinical relevance and medical applications. Integrating a spectrum of internationally-recognized experts currently developing these technologies, this book fits as a cornerstone of this exciting field. These include contributions from clinician scientists working at the interface of medicine and nanotechnologies which discuss the critical and requisite properties of nanomaterials, in a concise and cohesive manner. Nanodiamonds: Applications in Biology and Nanoscale Medicine provides a multidisciplinary overview of nanodiamonds and there uses for scientific, engineering and clinical audiences alike.

Ho Nanodiamonds jetzt bestellen!

Autoren/Hrsg.


Weitere Infos & Material


1;Preface;6
2;Prof. Dean Ho Biography;7
3;Contents;8
4;Contributors;10
5;Chapter 1;13
5.1;Single-Nano Buckydiamond Particles;13
5.1.1;1.1 .Introduction;13
5.1.2;1.2 .Formation and Isolation;16
5.1.2.1;1.2.1 .Detonation and Agglutination;16
5.1.2.2;1.2.2 .Isolation of Primary Particles;18
5.1.2.2.1;1.2.2.1 .Operation of Beads-Milling;21
5.1.2.2.1.1;.Operation Under the Optimum Condition;21
5.1.2.2.2;1.2.2.2 .Other Methods of Disintegrating Agglutinates;23
5.1.2.2.3;1.2.2.3 .Miniature Beads-Mill for Laboratory Testing;24
5.1.3;1.3 .Characteristics;25
5.1.3.1;1.3.1 .Spontaneous Polarization;25
5.1.3.2;1.3.2 .Hydration;26
5.1.3.3;1.3.3 .Mechanism of Ligand Exchange;28
5.1.3.4;1.3.4 .Core-Shell Structure;30
5.1.3.5;1.3.5 .Black Color;32
5.1.4;1.4 .Applications;32
5.1.4.1;1.4.1 .Three Major Uses Under Developments;32
5.1.4.1.1;1.4.1.1 .Inactivated Drug Carrier/Slow-Releaser;33
5.1.4.1.2;1.4.1.2 .CVD Seeding;33
5.1.4.1.2.1;.Experimental Procedure Involving Si-Wafer as the Substrate of Seeding;34
5.1.4.1.3;1.4.1.3 .Nanospacer Colloid Lubrication;36
5.1.4.2;1.4.2 .Other Favorable Assets of SNBD as Industrial Material;38
5.1.5;1.5 .Perspectives and Conclusions;42
5.1.5.1;1.5.1 .Cost Perspectives;42
5.1.5.2;1.5.2 .Conclusions;43
5.2;References;43
6;Chapter 2;46
6.1;Molecular Dynamics Simulations of Nanodiamond Graphitization;46
6.1.1;2.1 .Introduction;46
6.1.2;2.2 .Computational Method;48
6.1.3;2.3 .Nanodiamond Structures;49
6.1.4;2.4 .Results;50
6.1.4.1;2.4.1 .Graphitization Mechanism;50
6.1.4.2;2.4.2 .Factors Affecting Graphitization;55
6.1.4.2.1;2.4.2.1 .Annealing Temperature;55
6.1.4.2.2;2.4.2.2 .Nanodiamond Shape;56
6.1.4.2.3;2.4.2.3 .Nanodiamond Size;58
6.1.4.2.4;2.4.2.4 .Hydrogen Termination;59
6.1.4.3;2.4.3 .Onion-Like Carbons;59
6.1.4.4;2.4.4 .Vibrational Spectra;62
6.1.5;2.5 .Summary and Outlook;63
6.2;References;64
7;Chapter 3;66
7.1;The Fundamental Properties and Characteristics of Nanodiamonds;66
7.1.1;3.1 .Introduction;66
7.1.2;3.2 .Detonation Nanodiamond Technology;67
7.1.2.1;3.2.1 .Technology of Synthesis;67
7.1.2.2;3.2.2 .Isolation of Diamond from Detonation Carbon;69
7.1.2.2.1;3.2.2.1 .Removal of Impurities and of the sp.2. Phase;69
7.1.2.2.2;3.2.2.2 .Deaggregation of Detonation Nanodiamond Particles;73
7.1.3;3.3 .Structure of the Detonation Soot and DND Particles;74
7.1.4;3.4 .Methods for Characterization and Modification of Detonation Nanodiamonds;77
7.1.4.1;3.4.1 .Electron Spin Resonance and Magnetic Studies;78
7.1.4.2;3.4.2 .Characterization of DND Surface by Infrared Absorption;79
7.1.4.3;3.4.3 .Functionalization of DND Surface;83
7.1.5;3.5 .Conclusion;85
7.2;References;85
8;Chapter 4;89
8.1;Detonation Nanodiamond Particles Processing, Modification and Bioapplications;89
8.1.1;4.1 .Introduction: Types of Nanodiamonds;89
8.1.2;4.2 .Detonation Nanodiamond Synthesis, Processing, and Modification;91
8.1.2.1;4.2.1 .Synthesis;92
8.1.2.2;4.2.2 .DND Postsynthesis Processing;93
8.1.2.3;4.2.3 .Detonation Nanodiamond Modification;95
8.1.2.3.1;4.2.3.1 .Deep Purification;96
8.1.2.3.2;4.2.3.2 .Fractionation;96
8.1.2.3.3;4.2.3.3 .Deagglomeration;99
8.1.2.3.4;4.2.3.4 .DND Surface Functionalization;100
8.1.2.3.5;4.2.3.5 .DND Zeta Potential;102
8.1.2.4;4.2.4 .“Modern” Detonation Nanodiamond;104
8.1.3;4.3 .Selected Biomedical Applications;106
8.1.3.1;4.3.1 .DND Optical Labels;107
8.1.3.1.1;4.3.1.1 .DND Photoluminescence;107
8.1.3.1.2;4.3.1.2 .Fluorescently Labeled DND;108
8.1.3.2;4.3.2 .DND Biofunctional Applications;110
8.1.3.2.1;4.3.2.1 .DND Electromanipulation;110
8.1.3.2.2;4.3.2.2 .DND Solid Phase Supports;112
8.1.3.2.3;4.3.2.3 .DMSO Solvent for DND;115
8.1.3.2.4;4.3.2.4 .Thermophoresis of DND;117
8.1.3.3;4.3.3 .DND Medical Applications;118
8.1.3.3.1;4.3.3.1 .DND Enterosorbents;118
8.1.3.3.2;4.3.3.2 .DND in Ballistic Delivery;118
8.1.3.3.3;4.3.3.3 .DND for Seeding of CVD Diamond Films;119
8.1.3.3.4;4.3.3.4 .DND in Health Care Products;120
8.1.4;4.4 .Future of DND Biomedical Applications;121
8.2;References;122
9;Chapter 5;127
9.1;Functionalization of Nanodiamond for Specific Biorecognition;127
9.1.1;5.1 .Introduction;127
9.1.2;5.2 .Production of Nanoscale Diamond;127
9.1.3;5.3 .The Structure of Detonation Nanodiamond;128
9.1.4;5.4 .Applications of Nanodiamond;129
9.1.5;5.5 .Functionalization of Nanodiamond with Aminophenylboronic Acid;129
9.1.5.1;5.5.1 .Suzuki Coupling Reaction;132
9.1.6;5.6 .Conclusion;134
9.2;References;135
10;Chapter 6;136
10.1;Development and Use of Fluorescent Nanodiamonds as Cellular Markers*;136
10.1.1;6.1 .Introduction;136
10.1.2;6.2 .Materials and Methods;139
10.1.2.1;6.2.1 .Nanodiamond Samples;139
10.1.2.1.1;6.2.1.1 .Synthetic Nanodiamonds;139
10.1.2.1.2;6.2.1.2 .Natural Nanodiamonds;140
10.1.2.2;6.2.2 .Production of FNDs;140
10.1.2.2.1;6.2.2.1 .High Energy Ion Irradiation;140
10.1.2.2.2;6.2.2.2 .Medium Energy Ion Irradiation;140
10.1.2.3;6.2.3 .Spectroscopic Characterization of FNDs;141
10.1.2.3.1;6.2.3.1 .Ensemble Measurements;141
10.1.2.3.2;6.2.3.2 .Single Particle Measurements;142
10.1.2.4;6.2.4 .Biological Use of FNDs;144
10.1.2.4.1;6.2.4.1 .Cell Culture;144
10.1.2.4.2;6.2.4.2 .Flow Cytometry;144
10.1.2.4.3;6.2.4.3 .Fluorescence Microscopy;144
10.1.3;6.3 .Results and Discussion;145
10.1.3.1;6.3.1 .Mass-produced FNDs;145
10.1.3.2;6.3.2 .Multicolored FNDs;146
10.1.3.2.1;6.3.2.1 .Red FNDs;146
10.1.3.2.2;6.3.2.2 .Green FNDs;147
10.1.3.3;6.3.3 .Single FNDs;148
10.1.3.3.1;6.3.3.1 .Fluorescence Spectra;148
10.1.3.3.2;6.3.3.2 .Photostability and Fluorescence Brightness;149
10.1.3.3.3;6.3.3.3 .Fluorescence Lifetimes;152
10.1.3.4;6.3.4 .Applications of FNDs as Cellular Markers;152
10.1.3.4.1;6.3.4.1 .Cellular Uptake;152
10.1.3.4.2;6.3.4.2 .Single Particle Imaging and Tracking;154
10.1.4;6.4 .Conclusion and Future Work;156
10.2;References;157
11;Chapter 7;160
11.1;Nanodiamond-Mediated Delivery of Therapeutics via Particle and Thin Film Architectures;160
11.1.1;7.1 .Introduction;161
11.1.2;7.2 .ND Preparation, Characterization, and Dispersion;164
11.1.3;7.3 .ND Thin Film Fabrication via LBL Assembly;165
11.1.4;7.4 .ND-Mediated Loading and Release of Doxorubicin Hydrochloride (Dox);167
11.1.5;7.5 .Therapeutic Drug Functionalization of NDs;170
11.1.6;7.6 .Therapeutic Release from ND Thin Films;170
11.1.7;7.7 .Visualization of ND–Cell Interaction;171
11.1.8;7.8 .Examination of Innate Biocompatibility of ND Delivery Systems;173
11.1.9;7.9 .Cytotoxicity Analysis of ND–Cell Interfacing;177
11.1.10;7.10 .Dox–ND-Induced Cellular Apoptosis;178
11.1.11;7.11 .DNA Assay for Dox–ND Composite Driven Cell Death;179
11.1.12;7.12 .MTT Assay of Dox–ND Activity in HT-29 Colorectal Cancer Cell Line;180
11.1.13;7.13 .Conclusion;180
11.2;References;181
12;Chapter 8;184
12.1;Polymeric Encapsulation of Nanodiamond–Chemotherapeutic Complexes for Localized Cancer Treatment;184
12.1.1;8.1 .Introduction;185
12.1.2;8.2 .Materials and Methods;186
12.1.2.1;8.2.1 .ND Suspension and Functionalization with DOX;186
12.1.2.2;8.2.2 .Materials and Device Fabrication;186
12.1.2.3;8.2.3 .Atomic Force Microscopy Characterization;187
12.1.2.4;8.2.4 .Spectroscopic Analysis;187
12.1.2.5;8.2.5 .Contact Angle Measurements;187
12.1.2.6;8.2.6 .DNA Fragmentation Assay;187
12.1.3;8.3 .Results and Discussion;188
12.1.3.1;8.3.1 .Slow-release Analysis;191
12.1.3.2;8.3.2 .Biological Performance Assay;193
12.1.4;8.4 .Conclusions;195
12.2;References;196
13;Chapter 9;198
13.1;Protein–Nanodiamond Complexes for Cellular Surgery;198
13.1.1;9.1 .Introduction;198
13.1.2;9.2 .Nanodiamond’s Cytotoxicity;201
13.1.2.1;9.2.1 .The Cytotoxicity Test;201
13.1.3;9.3 .Using Nanodiamond as a Probe for BioDetections;204
13.1.4;9.4 .The Spectroscopic Properties of the Surface Functionalized Nanodiamond;204
13.1.4.1;9.4.1 .Infrared Spectroscopy of the Surface Functionalized Nanodiamond;204
13.1.4.2;9.4.2 .Raman Spectroscopy of Nanodiamond;211
13.1.4.3;9.4.3 .Fluorescence of Surface Functionalized Nanodiamond;213
13.1.4.4;9.4.4 .Confocal Fluorescence Imagining Using of Nanodiamond in Cell;217
13.1.4.4.1;9.4.4.1 .Confocal Fluorescence Microscopic Investigation;217
13.1.5;9.5 .Bio Molecules Conjugation to Nanodiamond;219
13.1.5.1;9.5.1 .Physical Adsorption;219
13.1.5.2;9.5.2 .Covalent Bonding;220
13.1.6;9.6 .The Interaction of ND–Protein Complex with Biological Cells;221
13.1.6.1;9.6.1 .Protein Lysozyme Interaction with Bacteria .E. coli;221
13.1.6.2;9.6.2 .Observing the Growth Hormone Receptors (GHR) Interacting with Growth Hormone (GH) through ND Labeling;223
13.1.7;9.7 .Nano Surgery Using Nanodiamond–Protein;227
13.1.8;9.8 .Conclusion;230
13.2;References;231
14;Chapter 10;234
14.1;Microfluidic Platforms for Nanoparticle Delivery and Nanomanufacturing in Biology and Medicine;234
14.1.1;10.1 .Introduction;235
14.1.2;10.2 .Tools for High Resolution Functional Nanoparticle Delivery;236
14.1.2.1;10.2.1 .Nanopatterning on Solid Substrates;236
14.1.2.1.1;10.2.1.1 .Directed Self-assembly;236
14.1.2.1.2;10.2.1.2 .Direct-write Nanopatterning;237
14.1.2.2;10.2.2 .In vitro Nanoparticle Injection;237
14.1.3;10.3 .Case Study: Nanofountain Probes for Functional Nanoparticle Delivery;238
14.1.3.1;10.3.1 .Direct-write Patterning of Functionalized Nanodiamonds;238
14.1.3.2;10.3.2 .Direct In vitro Injection;239
14.1.4;10.4 .Discussion and Concluding Remarks;240
14.2;References;241
15;Chapter 11;244
15.1;Biomechanics of Single Cells and Cell Populations;244
15.1.1;11.1 .Approaches in Single Cell Biomechanics;245
15.1.2;11.2 .Molecular Linkage to Cell Biomechanical Properties;246
15.1.3;11.3 .Biomechanics for Numerous Cells in a Population- An Emerging Need?;248
15.1.4;11.4 .Optical Profilometry for Higher Throughput Single Cell Biomechanical Profiling;250
15.2;References;254
16;Chapter 12;257
16.1;Design of Nanodiamond Based Drug Delivery Patch for Cancer Therapeutics and Imaging Applications;257
16.1.1;12.1 .Introduction;257
16.1.2;12.2 .The Drug Delivery Patch;260
16.1.2.1;12.2.1 .Number Effect in Nanoparticles;261
16.1.2.1.1;12.2.1.1 .What is the Number Effect?;261
16.1.2.1.2;12.2.1.2 .Nanospacers Lubrication;263
16.1.2.1.3;12.2.1.3 .Remarks on the Number Effect;265
16.1.3;12.3 .Materials and Manufacturing;266
16.1.3.1;12.3.1 .High Frequency Plasma-Enhanced Chemical Vapor Deposition (PECVD) for ND Particles and Film Synthesis and Processing;266
16.1.4;12.4 .Device Design Roadmap;269
16.1.5;12.5 .Structure and Surface Electrostatics of Nanodiamonds;270
16.1.5.1;12.5.1 .Uncertainty Quantification of ND charge;270
16.1.5.2;12.5.2 .Multiscale Analysis of ND charge;272
16.1.5.2.1;12.5.2.1 .Charge and Potential on (100) Surface;274
16.1.5.2.2;12.5.2.2 .Charge and Potential on (111) Surface;276
16.1.6;12.6 .ND–Drug Interactions;277
16.1.6.1;12.6.1 .Functionalization of Nanodiamonds;277
16.1.6.2;12.6.2 .Conjugation With Single-Stranded DNA Through .p.-Stacking;277
16.1.6.3;12.6.3 .Electrostatic Interactions Between Doxorubicin and Functionalized Nanodiamond;278
16.1.6.4;12.6.4 .Fundamental Theory of Electrostatic Interactions Between Charged Particles;278
16.1.6.5;12.6.5 .pH-Dependent Adsorption–Desorption;279
16.1.7;12.7 .ND-Drug Diffusion Through Porous Parylene;280
16.1.7.1;12.7.1 .Fundamental Theory;280
16.1.7.2;12.7.2 .Diffusion Through Porous Parylene and Continuum Model;281
16.1.8;12.8 .Diagnostic Nanodiamonds;284
16.1.8.1;12.8.1 .Imaging Applications as BioMarkers;284
16.1.8.2;12.8.2 .Imaging Functionality of Nanodiamond;284
16.1.9;12.9 .Summary and Conclusions;287
16.2;References;288



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.